Multiple Endocrine Neoplasia Type 2A
4 clinical trials · Condition
◉ Watch Multiple Endocrine Neoplasia Type 2A
| Record | Firm | Date |
|---|---|---|
| Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor (NCT02831179) | Vanderbilt-Ingram Cancer Center | 2017-12-01 |
| Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford (NCT01793168) | Sanford Health | 2010-07-01 |
| Vandetanib to Treat Children and Adolescents With Medullary Thyroid Cancer (NCT00514046) | National Cancer Institute (NCI) | 2007-07-20 |
| Sorafenib Tosylate in Treating Patients With Metastatic, Locally Advanced, or Recurrent Medullary Thyroid Cancer (NCT00390325) | National Cancer Institute (NCI) | 2006-11-03 |
Track Multiple Endocrine Neoplasia Type 2A automatically
Every clearance here is in the API, with alerts when new ones post.